Angiogenesis Assays Market Snapshot (2023 to 2033)

The anticipated size of the Angiogenesis Assays Market in 2022 was USD 1,972.1 million and is estimated to be USD 2,139.7 million in 2023. Increase in demand for angiogenesis assays majorly used in academic institutions and biotech companies is also contributing to the growth of this market.

Future Market Insights has mentioned in its reports that the automotive composites market will expand at a CAGR of 9.10% between 2023 and 2033, totaling around USD 5,112.2 million by 2033.

Angiogenesis is the process of the formation of new blood vessels from pre-existing vasculature where it involves the proliferation, migration, and differentiation of endothelial cells which leads to increased vascularization because this process is physiologically important for the development and wound healing and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer.

North America is considered to be a dominant region for the Angiogenesis Assay Market, owing to the increase in diseases such as tumor formulations, diabetic retinopathy, obesity, and metastasis.

Attribute Details
Projected Forecast Value (2022) USD 1,972.1 million
Projected Forecast Value (2023) USD 2,139.7 million
Projected Forecast Value (2033) USD 5,112.2 million
Growth rate 9.10% CAGR
Forecast period 2023 to 2033

Exclusive Offer: 30% Off on Regional Reports

Get a free sample report and customize your regions for a 30% discount on your regional report!

Angiogenesis Assays Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

The global angiogenesis assays market grew at a CAGR of 7.3% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 9.1% between 2023 and 2033.

Angiogenesis occurs in response to a variety of molecular cues as generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes.

Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however, the structures that form during pathological angiogenesis are often functionally abnormal.

Major factor that is expected to augment the growth of the angiogenesis assay market during the forecast period includes the increasing number of research and development activities in this field.

Factor that is expected to hinder the growth of the angiogenesis assay market during the forecast period includes the lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays

Which are Some Prominent Drivers Spearheading Angiogenesis Assay Market Growth?

Increase in the Number of Research and Development Activities

Major factor that is expected to drive the growth of the angiogenesis assay market during the forecast period includes an increasing number of research and development activities in this field. Rising Research and Development spending on cancer therapeutics is another major factor that is expected to fuel market growth.

Rise in Medical Tourism in Different Regions

Other factors that are anticipated to accelerate the growth of the angiogenesis assay market during the forecast period include increasing medical tourism in some regions. Factors such as the availability of government initiatives supporting research activities and product development are also favoring market growth.

Get Brochure on Email

Almost 80% of our clients request uniquely tailored intelligence.

What are the Challenges Faced by the Angiogenesis Assay Industry?

Biochemical Analysis of the Molecular Events

Major factor that is expected to hamper the growth of the angiogenesis assay market during the forecast period includes scaling up this technique, which tends to make a biochemical analysis of the molecular events mediating wound repair difficult.

Lack of Angiogenesis’ Accurate Analysis

Challenge that hinders market growth includes the lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays currently in use.

Region-wise Analysis

How is North America Emerging as an Opportunistic Angiogenesis Assay Market?

Increase in Developed Infrastructure, High Spending Capacity as well as Strict Regulations

North America holds the major share of the market, attributed to the developed infrastructure, high spending capacity as well as strict regulations in the angiogenesis assay market with a market share of 38.1%

United States factor expected to accelerate the market growth in the region includes the increase in diseases such as tumor formulations, diabetic retinopathy, obesity, and metastasis with a market share of 43.0%. North American angiogenesis assay market is expected to expand at an 8% CAGR during the forecast period

How is Asia Pacific Contributing to the Growth of the Angiogenesis Assay Market?

Rise in Investments from the Manufacturers

Future Market Insights says that Asia Pacific is anticipated to witness growth at a lucrative rate over the forecast period, owing to the increased investments from the manufacturers.

Asia Pacific countries including India are said to grow at a CAGR of 10.9% and China’s growth at a CAGR of 10.2% is anticipated to favor the growth of the angiogenesis assay market during the forecast period, attributed to the rising prevalence of the chronic diseases, and increasing cell-based studies in the region including Australia growing at a CAGR of 8.7% and Japan holding the value share of 5.3%.

Why is the European Market for Angiogenesis Assay Market said to be Rising?

Boost the Focus of Research and Regenerative Medicine for the Market

Europe is said to hold a market share of 29.3% after North America, where the United Kingdom and Germany are said to hold a major portion in this market where United Kingdom grows at a CAGR of 8.1% whereas Germany has a value share of 6.7%

Check Free Sample Report & Save 40%!

Select your niche segments and personalize your insights for smart savings. Cut costs now!

Category-wise Analysis

Which Product is said to have a Dominant Position in the Market?

Angiogenesis Tube Formation Assays are said to Hold a Dominant Position

Angiogenesis tube formation assays are said to hold a major market share of 52.3% where new blood vessels will be formed from pre-existing vessels. Angiogenesis plays an important role in physiological and pathological conditions like wound healing, embryonic development, cancer growth, etc.

Which Application is said to be Faring?

In-vitro Angiogenesis Application is Said to be Faring

In-vitro application angiogenesis holds a market share of 63.0% as the device is used in the measurement of protein or any other substance present in biological fluids and tissues, like blood, urine, serum, or tissue.

Which End-User is Said to be the Most in Demand?

Hospitals are considered to be the Most in Demand

Hospitals hold a value share of 48.0% in this market as the treatment for angiogenesis assays can be taken with proper care in hospitals itself.

Competitive Analysis

Some of the prominent players in the global market are-

  • Cell Biolabs, Inc.
  • Thermo Fisher Scientific
  • Abcam plc.
  • PromoCell GmbH
  • Merck KGaA
  • ATCC
  • Corning Incorporated
  • Bio-Techne
  • Molecular Devices, LLC
  • BioVision, Inc

Some of the important developments of the key players in the market are:

  • In May 2023, A new associate clinical research associate (ACRA) professional development program at Merck, known as MSD outside the United States and Canada, aims to increase and diversify the clinical research workforce. The program welcomes and trains new employees who do not have a CRA background but have transferable skills.
  • In April 2023, BioVisionCenter (BVC) is a recently launched new research center situated at the Irchel campus of the University of Zurich (UZH). Its mission is to become a worldwide leading research center for the promotion of comprehensive, scientific bioimage data exploration. Besides developing and implementing new technologies, the BVC will provide a computational platform as a service to its users that enables scalable bioimage analysis across multiple modalities and scales, from cryo-EM to whole organ imaging.

Scope of Report

Attribute Details
Growth Rate CAGR of 9.10% from 2023 to 2033
Market value in 2023 USD 2,139.7 million
Market value in 2033 USD 5,112.2 million
Base Year for Estimation 2022
Historical Data 2017 to 2022
Forecast Period 2023 to 2033
Quantitative Units USD million for Value and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered By Product Type, By Application, By End-user, By Region
Regions Covered North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East & Africa
Key Countries Profiled United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel, Rest of MEA
Key Companies Profiled Cell Biolabs, Inc.; Thermo Fisher Scientific; Abcam plc.; PromoCell GmbH; Merck KGaA; ATCC; Corning Incorporated; Bio-Techne; Molecular Devices, LLC; BioVision, Inc
Customisation Scope Available on Request
Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
  • 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
    • 5.1. Angiogenesis Tube Formation Assays
    • 5.2. Microfluidic
    • 5.3. Endothelial Adhesion
    • 5.4. Invasion and Migration Assays
  • 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
    • 6.1. In Vitro Angiogenesis
    • 6.2. In Vivo Angiogenesis
  • 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By User
    • 7.1. Hospitals
    • 7.2. Specialty Clinics
    • 7.3. Ambulatory Surgical Centers
  • 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
    • 8.1. North America
    • 8.2. Latin America
    • 8.3. Western Europe
    • 8.4. Eastern Europe
    • 8.5. South Asia and Pacific
    • 8.6. East Asia
    • 8.7. Middle East and Africa
  • 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 11. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 12. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 13. South Asia and Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 16. Key Countries Market Analysis
  • 17. Market Structure Analysis
  • 18. Competition Analysis
    • 18.1. Cell Biolabs, Inc.
    • 18.2. Thermo Fisher Scientific
    • 18.3. Abcam plc.
    • 18.4. PromoCell GmbH
    • 18.5. Merck KGaA
    • 18.6. ATCC
    • 18.7. Corning Incorporated
    • 18.8. Bio-Techne
    • 18.9. Molecular Devices, LLC
    • 18.10. BioVision, Inc.
  • 19. Assumptions & Acronyms Used
  • 20. Research Methodology

Key Segments Profiled in the Angiogenesis Assay Industry Survey

By Product Type:

  • Angiogenesis Tube Formation Assays
  • Microfluidic
  • Endothelial Adhesion
  • Invasion and Migration Assays

By Application:

  • In Vitro Angiogenesis
  • In Vivo Angiogenesis

By End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • China
  • Japan
  • Middle East & Africa

Frequently Asked Questions

What is the Market Value in 2023? 

The market is valued at USD 2.1 billion in 2023. 

What is the CAGR from 2023 to 2033? 

The market’s CAGR from 2023 to 2033 will be 9.1%. 

Who are the Key Market Players? 

Cell Biolabs, Inc., Thermo Fisher Scientific, and Abcam plc are the key market players. 

How was the Historical Performance of the Market? 

The market captured a CAGR of 7.3% from 2017 to 2022.

What is the Estimated Market Size in 2033? 

The market is estimated to reach USD 5.1 billion by 2033. 

Recommendations

Luciferase Assay Market
Market Size, 2024 USD 1,536.70 million
Market Size, 2034 USD 3,022.90 million
Value CAGR (2024 to 2034) 7.00%
Lateral Flow Assays Market
Market Estimated Size (2023) USD 4.3 billion
Market CAGR (2023 to 2033) 4.7%
Market Forecasted Size (2033) USD 6.9 billion
Cytotoxicity Assays Market
Expected Market Value (2022) USD 13,803.92 Million
Anticipated Forecast Value (2032) USD 32,978.94 Million
Projected CAGR (2022 to 2032) 9.1%

Explore Life Science & Biotechnology Insights

View Reports
Trusted By
Future Market Insights

Angiogenesis Assays Market

Schedule a Call